We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hamburg Calls for FDA to Use New Regulatory Science
Hamburg Calls for FDA to Use New Regulatory Science
September 18, 2009
The FDA must use the emerging technologies of genomic and personalized medicine, stem cell research and nanotechnology in healthcare, FDA Commissioner Margaret Hamburg said.